Digital PCR (dPCR) and Realtime PCR (qPCR) Market – Industry Structure Evaluation, Demand Drivers Analysis, Regional Growth Analysis and Identification, Competitive Positioning Review & Global Market Size Forecast to 2034
Overview
Digital PCR (dPCR) and Realtime PCR (qPCR) Market size is expected to grow at a CAGR of 9% during the forecast period and the market size is expected to reach nearly USD 15.68 billion by 2034.
The report has covered the current short term and long term impact on the market, same will help decision makers to prepare the outline for short term and long term strategies for companies by region.
Digital PCR (dPCR) and Realtime PCR (qPCR) Market Growth Outlook
To know about the Research Methodology:-Request Free Sample Report
Digital PCR (dPCR) and Real-time PCR (qPCR) Market Dynamics:
With growing numbers of real-time PCR and qPCR consumers buying digital PCR because of the decrease in its cost, total quantification, better sensitivity, precision and better robustness; and with the qPCR and Digital PCR market projected to grow to US$ 4 billion by 2029, this conference delivers a timely occasion to learn first-hand about dPCR whereas also keeping up to date with latest enlargements and policies in qPCR and real-time PCR.
Clinical applications of PCRs. According to the data from Centers for Disease Control and Prevention (CDC), the number of deaths because of cancers in U.S. was 575,000 in 2010 and estimated to rise to 630,000 in 2021. This is mostly because of morbid lifestyle, heredity, and others. So, growing number of cancer cases and associated deaths found to be one of the key causes for largest share of clinical application in global market.
Digital PCR (dPCR) and Real-time PCR (qPCR) Market Regional Analysis:
North America is projected to be the largest market, followed by Europe, Asia-Pacific, Latin America, and Middle East & Africa. Higher implementation of innovative technologies, well recognized healthcare research and diagnostic industries, growing funding for qPCR and dPCR technologies, rising incidence & prevalence of infective and genetic diseases, constant
decrease in gene sequencing cost, and existence of key players in the region are responsible for largest share of North American market.
At the same time, Asia Pacific is projected to grow at a fastest CAGR because of rapidly emerging countries, rising aging population coupled with increasing incidence of genetic diseases, increase in government support for life science research, developing research & clinical trial outsourcing from the region, and increasing number of CROs.
The objective of the report is to present a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, industry-validated market data and projections with a suitable set of assumptions and methodology. The report also helps in understanding Digital PCR (dPCR) and Real-time PCR (qPCR) Market dynamics, structure by identifying and analyzing the market segments and project the global market size. Further, the report also focuses on the competitive analysis of key players by product, price, financial position, product portfolio, growth strategies, and regional presence. The report also provides PEST analysis, PORTER’s analysis, and SWOT analysis to address the question of shareholders to prioritizing the efforts and investment in the near future to the emerging segment in Digital PCR (dPCR) and Real-time PCR (qPCR) Market.
Digital PCR (dPCR) and Real-time PCR (qPCR) Market Key Highlights:
1. Digital PCR (dPCR) and Real-time PCR (qPCR) Market analysis and forecast, in terms of value.
2. Comprehensive study and analysis of market drivers, restraints and opportunities influencing the growth of the Digital PCR (dPCR) and Real-time PCR (qPCR) Market
3. Digital PCR (dPCR) and Real-time PCR (qPCR) Market segmentation on the basis of type, source, end-user, and region (country-wise) has been provided.
4. Digital PCR (dPCR) and Real-time PCR (qPCR) Market strategic analysis with respect to individual growth trends, future prospects along with the contribution of various sub-market stakeholders have been considered under the scope of study.
5. Digital PCR (dPCR) and Real-time PCR (qPCR) Market analysis and forecast for five major regions namely North America, Europe, Asia Pacific, the Middle East & Africa (MEA) and Latin America along with country-wise segmentation.
6. Profiles of key industry players, their strategic perspective, market positioning and analysis of core competencies are further profiled.
7. Competitive developments, investments, strategic expansion and competitive landscape of the key players operating in the Digital PCR (dPCR) and Real-time PCR (qPCR) Market are also profiled.
Digital PCR (dPCR) and Realtime PCR (qPCR) Market Recent Development
| Date | Company | Development | Impact |
|---|---|---|---|
| 04 February 2025 | Thermo Fisher Scientific Inc. | Thermo Fisher Scientific received U.S. FDA 510(k) clearance for its TaqPath Flu A, Flu B, COVID-19, and RSV Select Panel multiplex PCR assay. | The approval expands high-throughput qPCR diagnostic capabilities across clinical laboratories for multi-pathogen respiratory surveillance and co-infection testing. |
| 18 April 2025 | QIAGEN N.V. | QIAGEN launched new target-specific QIAcuity Digital PCR Assay Kits tailored for specialized cell and gene therapy workflows. | The expansion accelerates dPCR adoption in biopharmaceutical quality control by enabling precise, high-sensitivity viral vector and gene-editing quantification. |
| 30 June 2025 | Bio-Rad Laboratories, Inc. | Bio-Rad completed the $257.7 million acquisition of Stilla Technologies, integrating its high-multiplex Naica digital PCR system. | The transaction significantly consolidates Bio-Rad’s market share in droplet digital PCR (ddPCR), expanding its multiplexing capabilities for oncology and liquid biopsy diagnostics. |
| 07 July 2025 | Bio-Rad Laboratories, Inc. | Bio-Rad commercially launched four new Droplet Digital PCR (ddPCR) platforms, including the QX Continuum and QX700 Series systems. | The new line supports over 400,000 dPCR assays with up to 7-color multiplexing, streamlining workflows across translational research and molecular diagnostics. |
| 12 January 2026 | QIAGEN N.V. | QIAGEN partnered with Hamilton to launch an automated nanoplate handling integration on the Microlab STAR platform for QIAcuity dPCR systems. | The collaboration delivers end-to-end walkaway automation, improving assay reproducibility and high-throughput efficiency in regulated GMP biopharma environments. |
| 22 January 2026 | Thermo Fisher Scientific Inc. | Thermo Fisher launched the TaqMan Cells-to-CT HepatoExpress Kit, enabling direct gene expression qPCR profiling without RNA extraction. | The assay solution cuts total laboratory processing time down to 75 minutes, enhancing efficiency for high-throughput preclinical drug discovery research. |
Digital PCR (dPCR) and Real-time PCR (qPCR) Market Scope: Inquire before buying
| Digital PCR (dPCR) and Real-time PCR (qPCR) Market | |||
|---|---|---|---|
| Report Coverage | Details | ||
| Base Year: | 2025 | Forecast Period: | 2026-2034 |
| Historical Data: | 2020 to 2025 | Market Size in 2025: | US $ 7.22 Bn. |
| Forecast Period 2026 to 2034 CAGR: | 9% | Market Size in 2034: | US $ 15.68 Bn. |
| Segments Covered: | by Product | Instruments Reagents Software Services |
|
| by End User | Hospitals Diagnostic Labs Academia Pharma-Biotech CRO |
||
| by Application | Clinical Oncology Forensics |
||
Digital PCR (dPCR) and Real-time PCR (qPCR) Market by Region:
North America (United States, Canada and Mexico)
Europe (UK, France, Germany, Italy, Spain, Sweden, Austria and Rest of Europe)
Asia Pacific (China, South Korea, Japan, India, Australia, Indonesia, Malaysia, Vietnam, Taiwan, Bangladesh, Pakistan and Rest of APAC)
Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest of ME&A)
South America (Brazil, Argentina Rest of South America)
Digital PCR (dPCR) and Real-time PCR (qPCR) Market Key Players
The Global Digital PCR (dPCR) and Realtime PCR (qPCR) driven by infectious disease testing, oncology, and genetic research. It contains instruments, reagents, software, and services used to amplify and quantify nucleic acids (DNA and RNA).
| Company Name | Headquarters | Core Competencies |
| Thermo Fisher Scientific Inc. | Waltham, Massachusetts, USA | Real-time PCR systems, digital PCR platforms, molecular diagnostics, life science reagents |
| F. Hoffmann-La Roche Ltd. | Basel, Switzerland | qPCR systems, molecular diagnostics, clinical PCR assays |
| Bio-Rad Laboratories, Inc. | Hercules, California, USA | Digital PCR platforms, qPCR instruments, PCR reagents |
| QIAGEN N.V. | Venlo, Netherlands | Sample preparation, qPCR assays, molecular diagnostics, automation |
| Takara Bio Inc. | Kusatsu, Japan | PCR enzymes, qPCR kits, molecular biology reagents |
| Agilent Technologies, Inc. | Santa Clara, California, USA | qPCR instruments, genomics, nucleic acid analysis |
| bioMérieux | Marcy-l'Étoile, France | Molecular diagnostics, infectious disease PCR testing |
| Standard BioTools | South San Francisco, California, USA | Digital PCR, microfluidics, genomics, proteomics |
| Danaher Corporation | Washington, D.C., USA | Molecular diagnostics through subsidiaries such as Cepheid and Beckman Coulter |
| Abbott Laboratories | Abbott Park, Illinois, USA | Molecular diagnostics, PCR-based infectious disease testing |
| Merck KGaA | Darmstadt, Germany | PCR reagents, molecular biology products, laboratory solutions |
| Promega Corporation | Madison, Wisconsin, USA | PCR reagents, nucleic acid purification, molecular biology tools |
| Eppendorf SE | Hamburg, Germany | PCR consumables, laboratory automation, thermal cyclers |
| Analytik Jena GmbH+Co. KG | Jena, Germany | qPCR instruments, nucleic acid extraction, molecular diagnostics |
| Bioneer Corporation | Daejeon, South Korea | PCR instruments, molecular diagnostics, oligonucleotide synthesis |
| ELITechGroup | Puteaux, France | Molecular diagnostic assays, PCR automation, infectious disease testing |
| QuidelOrtho | San Diego, California, USA | Molecular diagnostics, PCR systems, infectious disease diagnostics |
| Revvity, Inc. | Waltham, Massachusetts, USA | PCR instrumentation, molecular diagnostics, genomic analysis (formerly PerkinElmer) |
| Sysmex Corporation | Kobe, Japan | Molecular diagnostics, clinical laboratory automation, PCR testing |
| Cepheid | Sunnyvale, California, USA | Real-time PCR systems, rapid molecular diagnostics, infectious disease testing |
Frequently Asked Questions:
1. Which region has the largest share in Global Digital PCR (dPCR) and Real-time PCR (qPCR) Market?
Ans: North America region held the highest share in 2025.
2. What is the growth rate of Global Digital PCR (dPCR) and Real-time PCR (qPCR) Market?
Ans: The Global Digital PCR (dPCR) and Real-time PCR (qPCR) Market is growing at a CAGR of 9% during forecasting period 2026-2034.
3. What is scope of the Global Digital PCR (dPCR) and Real-time PCR (qPCR) market report?
Ans: Global Digital PCR (dPCR) and Real-time PCR (qPCR) Market report helps with the PESTEL, PORTER, COVID-19 Impact analysis, Recommendations for Investors & Leaders, and market estimation of the forecast period.
4. Who are the key players in Global Digital PCR (dPCR) and Real-time PCR (qPCR) market?
Ans: The important key players in the Global Digital PCR (dPCR) and Real-time PCR (qPCR) Market are – Thermo Fisher Scientific, Inc., F. Hoffman-La Roche Ltd., Bio-Rad Laboratories, Inc., QIAGEN N.V., Takara Bio, Inc., gilent Technologies, Inc., bioMérieux S.A., Fluidigm Corporation, Danaher Corporation, Abbott Laboratories, Merck KGaA, Becton Dickinson and Company, Promega Corporation, Eppendorf AG, Analytik Jena AG, Meridian Bioscience, Enzo Life Sciences, Bioneer, ELITech Group, and Quidel Corporation.
5. What is the study period of this market?
Ans: The Global Digital PCR (dPCR) and Real-time PCR (qPCR) Market is studied from 2020 to 2034.